You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 12, 2024

LEVOLET Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Levolet patents expire, and when can generic versions of Levolet launch?

Levolet is a drug marketed by Genus Lifesciences and is included in one NDA. There are two patents protecting this drug.

The generic ingredient in LEVOLET is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Levolet

A generic version of LEVOLET was approved as levothyroxine sodium by MYLAN on June 5th, 2002.

  Try a Trial

Drug patent expirations by year for LEVOLET
Recent Clinical Trials for LEVOLET

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dr. Reddy's Laboratories LimitedPhase 4
Dr. Reddy's Laboratories Limited

See all LEVOLET clinical trials

US Patents and Regulatory Information for LEVOLET

LEVOLET is protected by two US patents.

Patents protecting LEVOLET

Thyroid hormone oral dosage forms and methods of using the same
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Thyroid hormone oral dosage forms and methods of using the same
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-001 Jun 6, 2003 AB1,AB2,AB3,AB4 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-010 Jun 6, 2003 AB1,AB2,AB3,AB4 RX No No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-005 Jun 6, 2003 AB1,AB2,AB3,AB4 RX No No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-003 Jun 6, 2003 AB1,AB2,AB3,AB4 RX No No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Genus Lifesciences LEVOLET levothyroxine sodium TABLET;ORAL 021137-007 Jun 6, 2003 AB1,AB2,AB3,AB4 RX No No ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.